Surgalign Holdings, Inc. (SRGA) has a consensus analyst rating of Buy, based on 5 analysts covering the stock. Of those, 4 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for SRGA is $3.50, representing a +1,813.6% upside from the current price of $0.1829. Price targets range from a low of $3.50 to a high of $3.50.
